SkinBioTherapeutics plc (AIM:SBTX)
11.50
-0.75 (-6.12%)
Jul 24, 2026, 3:51 PM GMT
SkinBioTherapeutics Balance Sheet
Financials in millions GBP. Fiscal year is July - June.
Millions GBP. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Cash & Equivalents | 3.12 | 4.78 | 0.8 | 1.31 | 1.8 | 4.61 |
Cash & Short-Term Investments | 3.12 | 4.78 | 0.8 | 1.31 | 1.8 | 4.61 |
Cash Growth | -34.62% | 496.75% | -38.95% | -27.32% | -60.85% | 113.51% |
Accounts Receivable | 0.76 | 0.76 | 0.4 | 0.19 | 0.14 | 0.27 |
Total Trade Receivables | 0.76 | 0.76 | 0.4 | 0.19 | 0.14 | 0.27 |
Inventory | 0.93 | 0.8 | 0.47 | 0.03 | 0.12 | - |
Other Current Assets | - | - | - | 0.18 | 0.27 | 0.18 |
Total Current Assets | 4.81 | 6.34 | 1.67 | 1.72 | 2.33 | 5.06 |
Net Property, Plant & Equipment | 0.67 | 0.73 | 0.12 | 0.17 | 0.13 | 0.14 |
Other Intangible Assets | 1.71 | 1.84 | 1.39 | 0.7 | 0.63 | 0.53 |
Goodwill | 2.42 | 2.42 | 2.04 | - | - | - |
Total Assets | 9.6 | 11.33 | 5.22 | 2.59 | 3.08 | 5.73 |
Accounts Payable | 0.65 | 1.28 | 0.5 | 0.5 | 0.48 | 0.38 |
Short-Term Debt | - | - | 0.74 | - | - | - |
Current Portion of Leases | 0.1 | 0.11 | 0.04 | 0.03 | 0.03 | 0.03 |
Other Current Liabilities | 0.03 | 0.28 | 0.53 | - | - | - |
Total Current Liabilities | 0.78 | 1.68 | 1.8 | 0.53 | 0.51 | 0.4 |
Long-Term Debt | 0.6 | 0.6 | - | - | - | - |
Long-Term Leases | 0.24 | 0.28 | 0.04 | 0.07 | 0.1 | 0.11 |
Other Long-Term Liabilities | - | - | 0.4 | - | - | - |
Total Long-Term Liabilities | 0.84 | 0.88 | 0.44 | 0.07 | 0.1 | 0.11 |
Total Liabilities | 1.63 | 2.56 | 2.25 | 0.6 | 0.61 | 0.52 |
Common Stock | 2.59 | 2.59 | 2.02 | 1.73 | 1.57 | 1.57 |
Additional Paid-in Capital | 21.09 | 21.09 | 14.95 | 11.39 | 8.76 | 8.76 |
Accumulated Other Comprehensive Income | 0.44 | 0.44 | - | - | 0.44 | 0.38 |
Retained Earnings | -16.14 | -15.34 | -14 | -11.12 | -8.29 | -5.5 |
Shareholders' Equity | 7.98 | 8.77 | 2.97 | 1.99 | 2.48 | 5.22 |
Total Liabilities & Equity | 9.6 | 11.33 | 5.22 | 2.59 | 3.08 | 5.73 |
Total Debt | 0.94 | 0.99 | 0.82 | 0.1 | 0.13 | 0.14 |
Net Cash (Debt) | 2.19 | 3.79 | -0.02 | 1.21 | 1.68 | 4.47 |
Net Cash Growth | -42.27% | - | - | -27.78% | -62.48% | 107.04% |
Net Cash Per Share | 0.01 | 0.02 | - | 0.01 | 0.01 | 0.03 |
Book Value | 7.98 | 8.77 | 2.97 | 1.99 | 2.48 | 5.22 |
Book Value Per Share | 0.03 | 0.04 | 0.02 | 0.01 | 0.02 | 0.04 |
Tangible Book Value | 3.85 | 4.51 | -0.46 | 1.29 | 1.85 | 4.69 |
Tangible Book Value Per Share | 0.02 | 0.02 | -0.00 | 0.01 | 0.01 | 0.03 |